Cart
sales@molnova.com
Vanillyl butyl ether
CAS No. 82654-98-6
Vanillyl butyl ether( —— )
Catalog No. M19151 CAS No. 82654-98-6
Vanillyl butyl ether (VBE)is a capsaicin analogue,induce sensory irritation in humans,Vanillyl butyl ether is an alkoxy-substituted benzyl derivative mainly used as a flavoring agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameVanillyl butyl ether
-
NoteResearch use only, not for human use.
-
Brief DescriptionVanillyl butyl ether (VBE)is a capsaicin analogue,induce sensory irritation in humans,Vanillyl butyl ether is an alkoxy-substituted benzyl derivative mainly used as a flavoring agent.
-
DescriptionVanillyl butyl ether (VBE)is a capsaicin analogue,induce sensory irritation in humans,Vanillyl butyl ether is an alkoxy-substituted benzyl derivative mainly used as a flavoring agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number82654-98-6
-
Formula Weight210.27
-
Molecular FormulaC12H18O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (475.58 mM)
-
SMILESCCCCOCC1=CC=C(O)C(OC)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Takaishi M,etal.Reciprocal effects of capsaicin and menthol on thermosensation through regulated activities of TRPV1 and TRPM8.J Physiol Sci. 2016 Mar;66(2):143-55.
molnova catalog
related products
-
ABD328
ABD328 (ABD-328) is an orally active, small molecule inhibitor of RANKL and TNF signalling that inhibits inflammation in vivo.
-
Forsythoside B
Forsythoside B binds to LPS and reduces the biological activity of serum LPS, and inhibits NF-κB activation. Forsythoside B inhibits the inflammatory response and has antioxidant properties.
-
Gue1654
Gue1654 is a selective OXE-R inhibitor that attenuates coronary artery ligation-induced ischemic myocardial injury and cardiomyocyte oxygen/glucose deprivation-induced injury in mice through activation of BCAT1.
